CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
- PMID: 11477410
- DOI: 10.1038/90675
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
Abstract
Chemokines are chemoattractant proteins that are divided into subfamilies based upon cysteine signature motifs termed C, CC, CXC and CX3C. Chemokines have roles in immunity and inflammation that affect cell trafficking and activation of T cells as well as cells of the innate immune system. We report here CX3C chemokine mimicry for the G glycoprotein of respiratory syncytial virus (RSV) and show binding to CX3CR1--the specific receptor for the CX3C chemokine fractalkine--and induction of leukocyte chemotaxis. We also show that CX3CR1 facilitates RSV infection of cells. Thus, G glycoprotein interaction with CX3CR1 probably plays a key role in the biology of RSV infection.
Similar articles
-
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.J Infect Dis. 2004 Dec 1;190(11):1936-40. doi: 10.1086/425516. Epub 2004 Oct 28. J Infect Dis. 2004. PMID: 15529257 Clinical Trial.
-
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.J Immunol. 2006 Feb 1;176(3):1600-8. doi: 10.4049/jimmunol.176.3.1600. J Immunol. 2006. PMID: 16424189
-
T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis.Pediatr Infect Dis J. 2006 May;25(5):410-4. doi: 10.1097/01.inf.0000214998.16248.b7. Pediatr Infect Dis J. 2006. PMID: 16645504
-
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S46-57. doi: 10.1097/01.inf.0000108192.94692.d2. Pediatr Infect Dis J. 2004. PMID: 14730270 Review.
-
Fractalkine in vascular biology: from basic research to clinical disease.Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):34-40. doi: 10.1161/01.ATV.0000095360.62479.1F. Epub 2003 Sep 11. Arterioscler Thromb Vasc Biol. 2004. PMID: 12969992 Review.
Cited by
-
Molecular mechanisms driving respiratory syncytial virus assembly.Future Microbiol. 2013 Jan;8(1):123-31. doi: 10.2217/fmb.12.132. Future Microbiol. 2013. PMID: 23252497 Free PMC article. Review.
-
Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.J Virol. 2004 Jun;78(11):5773-83. doi: 10.1128/JVI.78.11.5773-5783.2004. J Virol. 2004. PMID: 15140975 Free PMC article.
-
Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.J Virol. 2004 Jun;78(11):6024-32. doi: 10.1128/JVI.78.11.6024-6032.2004. J Virol. 2004. PMID: 15141000 Free PMC article.
-
Immune responses and disease enhancement during respiratory syncytial virus infection.Clin Microbiol Rev. 2005 Jul;18(3):541-55. doi: 10.1128/CMR.18.3.541-555.2005. Clin Microbiol Rev. 2005. PMID: 16020689 Free PMC article. Review.
-
Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.PLoS Pathog. 2018 Aug 24;14(8):e1007262. doi: 10.1371/journal.ppat.1007262. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30142227 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous